Stephanie Pond

Stephanie Pond Ph.D.

Vice President, Emerging Technologies

Stephanie Pond Ph.D.

Dr. Stephanie Pond is the Vice President of Emerging Opportunities at TGen and is focused on accelerating the adoption of new technologies into translational medicine.  Dr. Pond oversees TGen’s Scientific Technology Research Team (START) which identifies, evaluates, and transfers transformational technologies into the organization to support TGen’s strategic aims.  Dr. Pond  leads TGen’s Enterprise Directed Programs (EDP),  an initiative to commercialize TGen developed technologies which have a high potential for clinical impact and to accelerate research discoveries from the “bench to bedside” through technology development, technology transfer, industry partnerships, and commercialization.   

Prior to joining TGen, Dr. Pond worked on product development in diverse areas of research such as biophysics, genetics, oncology, forensic science, genetics assay development, and in different environments (academic, small start-up, large biotech company, CLIA laboratories). Her expertise in these areas has focused on method/technology development and transfer of that technology to customers.

Dr. Pond has worked at a number of biotechnology companies including leading the Applied Genomics R&D team at Illumina, co-founding GalaxyWorks, and building research and operational capabilities at Prognosys Biosciences.

Dr. Pond received her BA in Chemistry and Physics from Westminster College and PhD in Physical Chemistry from the University of Arizona.

Jager AC, Alverez ML, Davis CP, Guzman E, Han Y, Walichiewicz P, Silva D, Pham N, Caves G, Bruand J, Schlesinger F, Pond SJK, Varlaro J, Stephens KM, Holt CL. (2017) Developmental validation of the MiSeq FGx Forensic Genomics System for Targeted Net Generation Sequencing in Forensic DNA Casework and Database Laboratories.Forensic Science International Genetics 28, 52

Craig CW, Nasser S, Corbett R, Chan SK, Murray L, Legendre C, Tembe W, Adkins, J, Kim N, Wong S, Baker A, Enriquez D, Pond S, Pleasance E, Mungall AJ, Moore RA, McDaniel T, Ma Y, Jones SJM, Marra MA, Carpten JD, Liang WS. (2016) A somatic reference standard for cancer genome sequencing. Scientific Reports, 6, 24607. 

Tembe WD, Pond SJK, Legendre C, Chuang HY, Liang WS, Kim NE, Montel V, Wong S, McDaniel TK, Craig DW, Carpten JD. (2014) Open-access synthetic spike-in mRNA-Seq data for cancer gene fusions.BMC genomics 15(1), 824.

Kozlov IA, Thomsen ER, Munchel SE, Villegas P, Capek P, Gower AJ, Pond SJK, Chudin E, Chee MS. (2012) A Highly Scalable Peptide-Based Assay System for Proteomics. PLoS One, 7(6), e37441.

Harismendy O, Schwab RB, Bao L, Olson J, Rozenzhak S, Kotsopoulos SK, Pond SJK, Crain B, Chee MS, Messer K, Link DR, Frazer KA.(2011) Detection of low prevalence somatic mutations in solid tumors with ultra-deep targeted sequencing.Genome Biology ,12(12), R124. 

Pond SJK, Ridgeway WK, Robertson R, Wang J, Millar DP. (2009) HIV-1 Rev Protein Assembles on Viral RNA One Molecule at a Time. Proceedings of the National Academy of Sciences,106(5), 1404-1408. 

Rumi M, Pond SJK, Meyer-Friedrichsen T, Zhang Q, Bishop M, Zhang Y, Barlow S, Marder SR, Perry JW. (2008) Tetrastyrylarene Derivatives: Comparison of One- and Two-Photon Spectroscopic Properties with Disytyrylarene Analogues.J. Phys. Chem. C, 112(21), 8061-8071.

Rumi M, Pond SJK, Zhang Q, Bishop M, Zhang Y, Barlow S, Marder SR, Perry JW. (2008) Two-Photon Absorption in Cross-Shaped Chromophores with Phenylene-Vinylene Backbones. Proceedings of SPIE, 6891.

Grover RK, Pond SJK, Cui Q, Subramaniam P, Case DA, Millar DP, Wentworth P Jr. (2007). O-Glycoside Orientation is an Essential Aspect of Base J Recognition by the Kinetoplastid DNA-Binding Protein JBP1. Angew. Chem. Int. Ed., 46(16), 2839-2943. 

Cai MY, Stankova M, Pond SJK, Mayorov AV, Perry JW, Yamamura HI, Trivedi, D, Hruby VJ. (2004) Real Time Differentiation of G-protein Coupled Receptor (GPCR) Agonist and Antagonist by Two Photon Fluorescence Laser Microscopy. J. Am. Chem. Soc, 126 (23), 7160-7161. 

Pond SJK, Tsutsumi O, Rumi M, Kwon O, Zojer E, Brédas, JL, Marder SR, Perry JW. (2004) Metal-Ion Sensing Fluorophores with Large Two-Photon Absorption Cross Sections: Aza- Crown Ether Substituted Donor-Acceptor-Donor Distryryl Benzenes. J. Am. Chem. Soc, 126.(37), 9291-9306.

Bartholomew GP, Rumi M, Pond SJK, Perry JW, Tretiak S, Bazan GC. (2004) Two-Photon Absorption in Three-Dimensional Chromophores Based on [2,2]-paracyclophane. J. Am. Chem. Soc, 126 (37), 11529-11542. 

Wenseleers W, Stellacci F, Meyer-Friedrichsen T, Mangel T, Bauer CA, Pond SJK, Marder SR, Perry JW. (2002) Five Orders-of-Magnitude Enhancement of Two-Photon Absorption for Dyes on Silver Nanoparticle Fractal Clusters. Journal of Physical Chemistry B, 106, 6853- 6863.  

Beljonne D, Zojer E, Shuai Z, Vogel H, Wenseleers W, Pond SJK, Perry JW, Marder, SR, Brédas JL. (2002) Role of Dimensionality on the Two-Photon Absorption Response of Conjugated Molecules: The Case of Octupolar Compounds. Advanced Functional Materials, 12(9), 631-641.  

Pond SJK, Rumi M, Levin MD, Parker TC, Beljonne D, Day MW, Brédas JL, Marder SR, Perry JW. (2002) One- and Two-Photon Spectroscopy of Donor-Acceptor-Donor Distyrylbenzene Derivatives: Effect of Cyano Substitution and Distortion from Planarity. Journal of Physical Chemistry A, 106 (47), 11470-11480.  

Stellacci F, Bauer CA, Meyer-Friedrichsen T, Wenseleers W, Alain V,Kuebler SM, Pond SJK, Zhang Y, Marder SR, Perry JW. (2002) Laser and Electron-Beam Induced Growth of Nanoparticles for 2D and 3D Metal Patterning. Advanced Materials, 14(3), 194-198.

Stellacci F, Bauer CA, Meyer-Friedrichsen T, Wenseleers W, Alain V, Kuebler SM, Pond SJK, Zhang Y, Marder SR, Perry JW. (2002). One- and Two-Photon Induced Growth of Ligand Coated Nanoparticles for 2 & 3D Metal Patterning. Proc. of SPIE, 4809, 62-68
Back To Top